ENTRY       D12257                      Drug
NAME        Gallium Ga 68 gozetotide (USAN);
            Gallium Ga-68 PSMA-11 (TN);
            Illuccix (TN);
            Locametz (TN)
PRODUCT     GALLIUM GA-68 PSMA-11 (UCLA Biomedical Cyclotron)
            GALLIUM GA-68 PSMA-11 (UCSF Radiopharmaceutical Facility)
            ILLUCCIX (Telix Pharmaceuticals (US))
            LOCAMETZ (Advanced Accelerator Applications USA)
FORMULA     C44H59N6O17. Ga
EXACT_MASS  1012.3193
MOL_WEIGHT  1013.6923
REMARK      ATC code: V09IX14
            Product: D12257<US>
EFFICACY    Diagnostic aid (prostate cancer), Radioactive agent
COMMENT     Radio-labeled imaging agent
TARGET      FOLH1 (PSMA) [HSA:2346] [KO:K14592]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             V VARIOUS
              V09 DIAGNOSTIC RADIOPHARMACEUTICALS
               V09I TUMOUR DETECTION
                V09IX Other diagnostic radiopharmaceuticals for tumour detection
                 V09IX14 Gallium (68Ga) gozetotide
                  D12257  Gallium Ga 68 gozetotide (USAN) &lt;US&gt;
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Metallocarboxypeptidases
                FOLH1 (PSMA)
                 D12257  Gallium Ga 68 gozetotide (USAN) &lt;US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D12257
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D12257
DBLINKS     CAS: 1906894-20-9
///
